In a second set of GBM tumor samples (n = 16, samples frozen at −80 °C), we used immunofluorescence to study the expression of SOX2 in larger regions of tumor tissue (rather than the cores of the TMA). This evidence concerns the gene SOX2 and glioblastoma.